Position
Chief Executive Officer
Company
Cocrystal Pharma, Inc.
Description
Cocrystal Pharma Inc. has appointed James Sapirstein as Chief Executive Officer, effective immediately. He replaces Sam Lee and Jim Martin, who were serving as Co-Chief Executive Officers.
Quick answer
Cocrystal Pharma Appoints James Sapirstein as Chief Executive Officer (June 3, 2026). Cocrystal Pharma, Inc. is based in Bothell, Washington, United States.
- Who is the new Chief Executive Officer at Cocrystal Pharma, Inc?
- Cocrystal Pharma, Inc. named James Sapirstein Chief Executive Officer, announced June 3, 2026.
- What did Cocrystal Pharma, Inc. announce on June 3, 2026?
- Cocrystal Pharma Inc. has appointed James Sapirstein as Chief Executive Officer, effective immediately. He replaces Sam Lee and Jim Martin, who were serving as Co-Chief Executive Officers.
- What does Cocrystal Pharma, Inc. do?
- Cocrystal (OTCQB:COCP) is a pharmaceutical company.
- Where is Cocrystal Pharma, Inc. based?
- Cocrystal Pharma, Inc. is based in Bothell, Washington, United States.
- Which similar companies made leadership changes around the same time?
- Change Agents Corporation. (June 4, 2026), Retension Pharmaceuticals (May 27, 2026), Ovid Therapeutics (July 14, 2026) and Jade Biosciences (April 23, 2026) also announced leadership changes within 45 days of Cocrystal Pharma, Inc.
Source: Fundz verified event record.
Other recent leadership changes in Healthcare and Therapeutics
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Avalon Appoints Sam Knipper as Chief Financial Officer (June 4, 2026)
- Retension Pharmaceuticals Appoints Alison Schecter as Chief Medical Officer and Alex Schwartz as Chief Financial Officer (May 27, 2026)
- Ovid Therapeutics Inc. Appoints Kevin Norrett as Chief Business Officer and Promotes Charles Carter to CFO (July 14, 2026)
- Jade Biosciences Appoints Edward R. Conner, M.D. as Chief Medical Officer (April 23, 2026)
- EyePoint Appoints Tarek S. Hassan as Senior Vice President, Chief Strategic Science Officer (July 14, 2026)
- Cue Biopharma Appoints Sumita Ray as Chief Legal & Compliance Officer (June 2, 2026)
Who to call at Cocrystal Pharma, Inc., and when
A new leader at Cocrystal Pharma, Inc. brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Cocrystal Pharma, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Cocrystal Pharma, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Cocrystal Pharma, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Cocrystal Pharma, Inc. changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Cocrystal Pharma, Inc. changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.